Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN IBS-C
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
UMSL, FOCUS St. Louis working together to grow leaders today and in the future
The university will collaborate with the nonprofit on events such as the Start with Leadership Conference, the Youth Leadership St. Louis Program and the new NextGen Leadership Program for UMSL students.
MORE IN IBS-C
LATEST NEWS
- UMSL, FOCUS St. Louis working together to grow leaders today and in the future
- UMSL Marketing and Communications wins three CASE Best of District VI Awards
- UMSL leaders showcase strategic communication and community impact at 2025 CUMU Conference
- Eric Zhang pursues passion for piano while also studying supply chain management
- Alum Georgeann McLemore returns to share her success story with current students
- Optometry student Grace Broach named to 2025-26 CooperVision Student Contact Lens Leadership Society
- UMSL Tritons weekly rewind
- Eye on UMSL: Performance time
- MasterCard VP Regina McWilliams’ DBA research accepted for journal publication
- Alum Quahana Hendree turns inspiration into corporate art consulting career
